You are here

  • Home
  • Archive
  • Volume 9, Issue Suppl 1
  • P06.03 Bispecific antibody-driven synthetic agonistic receptor engineered T cells lead to specific and conditional therapy in melanoma cancer models

Article metrics

Article menu

Download PDFPDF

Poster Presentations
P06 Cell Therapy in Solid Tumors
P06.03 Bispecific antibody-driven synthetic agonistic receptor engineered T cells lead to specific and conditional therapy in melanoma cancer models
Free

 

Online download statistics by month:

Online download statistics by month: October 2021 to September 2024

AbstractFullPdf
Oct 2021106015
Nov 20213807
Dec 20212402
Jan 20222201
Feb 20221803
Mar 202221600
Apr 2022603
May 202266010
Jun 20221202
Jul 2022801
Aug 20221601
Sep 2022806
Oct 2022806
Nov 2022802
Dec 20221202
Jan 2023403
Feb 2023800
Mar 2023802
Apr 2023407
May 2023600
Jun 2023001
Jul 2023403
Aug 20231003
Sep 2023401
Oct 20231002
Nov 20231002
Dec 20232201
Jan 20242201
Feb 20241206
Mar 202410036
Apr 20241006
May 2024600
Jun 2024203
Jul 2024402
Aug 20241204
Sep 20241201
Total7480145